• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项丹麦普通人群研究中,健康的生活方式可降低可溶性尿激酶型纤溶酶原激活物受体(suPAR)水平及死亡率。

Healthy lifestyles reduce suPAR and mortality in a Danish general population study.

作者信息

Haupt Thomas Huneck, Rasmussen Line Jee Hartmann, Kallemose Thomas, Ladelund Steen, Andersen Ove, Pisinger Charlotta, Eugen-Olsen Jesper

机构信息

1Clinical Research Centre, Amager and Hvidovre Hospital, Hvidovre, Denmark.

2Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Immun Ageing. 2019 Jan 22;16:1. doi: 10.1186/s12979-018-0141-8. eCollection 2019.

DOI:10.1186/s12979-018-0141-8
PMID:30679937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6343248/
Abstract

BACKGROUND

The plasma level of the inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is a strong predictor of disease development and premature mortality in the general population. Unhealthy lifestyle habits such as smoking or unhealthy eating is known to elevate the suPAR level. We aimed to investigate whether change in lifestyle habits impact on the suPAR level, and whether the resultant levels are associated with mortality.

RESULTS

Paired suPAR measurements from baseline- and the 5-year visit of the population-based Inter99 study were compared with the habits of diet, smoking, alcohol consumption, and physical activity. Paired suPAR measurements for 3225 individuals were analyzed by linear regression, adjusted for demographics and lifestyle habits. Compared to individuals with a healthy lifestyle, an unhealthy diet, low physical activity, and daily smoking were associated with a 5.9, 12.8, and 17.6% higher 5-year suPAR, respectively. During 6.1 years of follow-up after the 5-year visit, 1.6% of those with a low suPAR (mean 2.93 ng/ml) died compared with 3.8% of individuals with a high suPAR (mean 4.73 ng/ml),  <  0.001. In Cox regression analysis, adjusted for demographics and lifestyle, the hazard ratio for mortality per 5-year suPAR doubling was 2.03 (95% CI: 1.22-3.37).

CONCLUSION

Lifestyle has a considerable impact on suPAR levels; the combination of unhealthy habits was associated with 44% higher 5-year suPAR values and the 5-year suPAR was a strong predictor of mortality. We propose suPAR as a candidate biomarker for lifestyle changes as well as the subsequent risk of mortality.

摘要

背景

炎症生物标志物可溶性尿激酶型纤溶酶原激活剂受体(suPAR)的血浆水平是普通人群疾病发展和过早死亡的有力预测指标。已知吸烟或不健康饮食等不良生活习惯会升高suPAR水平。我们旨在研究生活习惯的改变是否会影响suPAR水平,以及由此产生的水平是否与死亡率相关。

结果

将基于人群的Inter99研究中基线和5年随访时的配对suPAR测量值与饮食、吸烟、饮酒和身体活动习惯进行比较。通过线性回归分析了3225名个体的配对suPAR测量值,并对人口统计学和生活习惯进行了调整。与生活方式健康的个体相比,不健康饮食、低身体活动和每日吸烟分别与5年suPAR升高5.9%、12.8%和17.6%相关。在5年随访后的6.1年随访期间,suPAR水平低(平均2.93 ng/ml)的人群中有1.6%死亡,而suPAR水平高(平均4.73 ng/ml)的人群中有3.8%死亡,P<0.001。在Cox回归分析中,对人口统计学和生活方式进行调整后,每5年suPAR翻倍的死亡风险比为2.03(95%CI:1.22-3.37)。

结论

生活方式对suPAR水平有相当大的影响;不良习惯的组合与5年suPAR值高44%相关,5年suPAR是死亡率的有力预测指标。我们建议将suPAR作为生活方式改变以及随后死亡风险的候选生物标志物。

相似文献

1
Healthy lifestyles reduce suPAR and mortality in a Danish general population study.在一项丹麦普通人群研究中,健康的生活方式可降低可溶性尿激酶型纤溶酶原激活物受体(suPAR)水平及死亡率。
Immun Ageing. 2019 Jan 22;16:1. doi: 10.1186/s12979-018-0141-8. eCollection 2019.
2
Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.可溶性尿激酶型纤溶酶原激活物受体与饮食质量呈线性相关,并可预测死亡率。
Br J Nutr. 2019 Mar;121(6):699-708. doi: 10.1017/S0007114518003720. Epub 2019 Jan 10.
3
Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population.普通人群中与炎症生物标志物可溶性尿激酶型纤溶酶原激活物受体血清水平相关的危险因素。
Biomark Insights. 2014 Dec 16;9:91-100. doi: 10.4137/BMI.S19876. eCollection 2014.
4
Associations of suPAR with lifestyle and cardiometabolic risk factors.可溶性尿激酶型纤溶酶原激活物受体(suPAR)与生活方式及心血管代谢危险因素的关联。
Eur J Clin Invest. 2014 Jul;44(7):619-26. doi: 10.1111/eci.12278. Epub 2014 May 22.
5
Effect of a physical activity intervention on suPAR levels: A randomized controlled trial.一项体力活动干预对 suPAR 水平的影响:一项随机对照试验。
J Sci Med Sport. 2018 Mar;21(3):286-290. doi: 10.1016/j.jsams.2017.06.018. Epub 2017 Jul 4.
6
suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.可溶性尿激酶型纤溶酶原激活物受体(suPAR)与急性入院的内科患者未来急性手术风险和术后死亡率相关。
Scand J Trauma Resusc Emerg Med. 2018 Feb 1;26(1):11. doi: 10.1186/s13049-018-0478-1.
7
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.可溶性尿激酶型纤溶酶原激活物受体可预测 COPD 恶化患者的死亡率。
Respir Res. 2018 May 21;19(1):97. doi: 10.1186/s12931-018-0803-2.
8
Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.可溶性尿激酶型纤溶酶原激活物受体可改善慢性心力衰竭患者的风险预测。
JACC Heart Fail. 2017 Apr;5(4):268-277. doi: 10.1016/j.jchf.2016.12.008.
9
Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.血浆可溶性尿激酶型纤溶酶原激活物受体与 CVD 的发生有关。马尔默饮食与癌症研究的结果。
Atherosclerosis. 2012 Feb;220(2):502-5. doi: 10.1016/j.atherosclerosis.2011.10.039. Epub 2011 Nov 9.
10
Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.急性护理中的可溶性尿激酶型纤溶酶原激活物受体(suPAR):疾病存在、严重程度、再入院和死亡率的有力标志物。一项回顾性队列研究。
Emerg Med J. 2016 Nov;33(11):769-775. doi: 10.1136/emermed-2015-205444. Epub 2016 Sep 2.

引用本文的文献

1
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为急性入院房颤患者的预后生物标志物。
J Arrhythm. 2025 Apr 23;41(2):e70077. doi: 10.1002/joa3.70077. eCollection 2025 Apr.
2
A regularized Bayesian Dirichlet-multinomial regression model for integrating single-cell-level omics and patient-level clinical study data.一种用于整合单细胞水平组学和患者水平临床研究数据的正则化贝叶斯狄利克雷多项回归模型。
Biometrics. 2025 Jan 7;81(1). doi: 10.1093/biomtc/ujaf005.
3
Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population.

本文引用的文献

1
Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.童年期累积风险与成年期慢性炎症的一个新衡量指标相关。
J Child Psychol Psychiatry. 2019 Feb;60(2):199-208. doi: 10.1111/jcpp.12928. Epub 2018 May 9.
2
Omen in the blood.血液中的征兆。
Science. 2018 Apr 20;360(6386):254-258. doi: 10.1126/science.360.6386.254. Epub 2018 Apr 19.
3
Cigarette smoke-induced inflammation: NLRP10-mediated mechanisms.香烟烟雾诱导的炎症:NLRP10 介导的机制。
比较新冠病毒疫苗同源接种与异源接种后的抗体反应:孟加拉国城市人口的横断面分析
Vaccines (Basel). 2025 Jan 13;13(1):67. doi: 10.3390/vaccines13010067.
4
Associations between social behaviour and proinflammatory immune activation are modulated by age in a free-ranging primate population.在一个野生灵长类种群中,社交行为与促炎免疫激活之间的关联受到年龄的调节。
Anim Behav. 2025 Jan;219. doi: 10.1016/j.anbehav.2024.10.035. Epub 2024 Dec 14.
5
Cannabis use in youth is associated with chronic inflammation.青少年使用大麻与慢性炎症有关。
Psychol Med. 2024 Dec 9;54(16):1-11. doi: 10.1017/S0033291724002848.
6
A Framework for an Effective Healthy Longevity Clinic.一个有效的健康长寿诊所框架。
Aging Dis. 2024 Jul 23. doi: 10.14336/AD.2024.0328-1.
7
Intestinal Permeability, Gut Inflammation, and Gut Immune System Response Are Linked to Aging-Related Changes in Gut Microbiota Composition: A Study in Female Mice.肠道通透性、肠道炎症和肠道免疫系统反应与肠道微生物组组成的衰老相关变化有关:一项雌性小鼠的研究。
J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4). doi: 10.1093/gerona/glae045.
8
Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease.可溶性尿激酶型纤溶酶原激活剂受体在心血管疾病中的作用
Curr Cardiol Rep. 2023 Dec;25(12):1797-1810. doi: 10.1007/s11886-023-01991-7. Epub 2023 Nov 10.
9
SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes.重度抑郁症中的可溶性尿激酶型纤溶酶原激活物受体:与26周抗抑郁反应及10年抑郁症转归的关联
Brain Behav Immun Health. 2023 Sep 7;33:100685. doi: 10.1016/j.bbih.2023.100685. eCollection 2023 Nov.
10
Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population.自评健康状况和慢性炎症相关,且与一般人群的住院和长期死亡率独立相关。
Sci Rep. 2022 Nov 17;12(1):19761. doi: 10.1038/s41598-022-24422-z.
Toxicology. 2018 Apr 1;398-399:52-67. doi: 10.1016/j.tox.2018.02.010. Epub 2018 Mar 6.
4
A tripartite complex of suPAR, APOL1 risk variants and αβ integrin on podocytes mediates chronic kidney disease.足细胞上的suPAR、APOL1风险变异体和αβ整合素三方复合物介导慢性肾脏病。
Nat Med. 2017 Aug;23(8):945-953. doi: 10.1038/nm.4362. Epub 2017 Jun 26.
5
Inflammation and post-operative recovery in patients undergoing total knee arthroplasty-secondary analysis of a randomized controlled trial.全膝关节置换术患者的炎症与术后恢复——一项随机对照试验的二次分析
Osteoarthritis Cartilage. 2017 Aug;25(8):1265-1273. doi: 10.1016/j.joca.2017.03.008. Epub 2017 Mar 16.
6
Soluble Urokinase Receptor and Chronic Kidney Disease.可溶性尿激酶受体与慢性肾脏病
N Engl J Med. 2015 Nov 12;373(20):1916-25. doi: 10.1056/NEJMoa1506362. Epub 2015 Nov 5.
7
Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism.可溶性尿激酶型纤溶酶原激活物受体与静脉血栓栓塞症的发生。
Thromb Haemost. 2016 Mar;115(3):657-62. doi: 10.1160/TH15-06-0511. Epub 2015 Oct 15.
8
Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population.普通人群中与炎症生物标志物可溶性尿激酶型纤溶酶原激活物受体血清水平相关的危险因素。
Biomark Insights. 2014 Dec 16;9:91-100. doi: 10.4137/BMI.S19876. eCollection 2014.
9
Motivational effects of coronary artery calcium scores on statin adherence and weight loss.冠状动脉钙化评分对他汀类药物依从性和体重减轻的激励作用。
Coron Artery Dis. 2015 May;26(3):225-30. doi: 10.1097/MCA.0000000000000207.
10
Soluble urokinase-type plasminogen activator receptor (suPAR) as new biomarker of the prosthetic joint infection: correlation with inflammatory cytokines.可溶性尿激酶型纤溶酶原激活物受体 (suPAR) 作为人工关节感染的新型生物标志物:与炎症细胞因子的相关性。
Clin Chim Acta. 2015 Feb 20;441:23-8. doi: 10.1016/j.cca.2014.11.029. Epub 2014 Dec 9.